首页> 外国专利> ASSESSMENT OF CANCER RISK BASED ON RNU2 CNV AND INTERPLAY BETWEEN RNU2 CNV AND BRCA1

ASSESSMENT OF CANCER RISK BASED ON RNU2 CNV AND INTERPLAY BETWEEN RNU2 CNV AND BRCA1

机译：基于RNU2 CNV的癌症风险评估以及RNU2 CNV和BRCA1之间的相互作用

页面导航

摘要
著录项
相似文献

摘要

Polynucleotides useful for detecting copy number variation of RNU2 sequences and methods of assessing risk of developing breast or ovarian cancer using molecular combing and/or detection or quantification of BRCA1 expression.

机译：多核苷酸可用于检测RNU2序列的拷贝数变异以及使用分子梳理和/或检测或定量BRCA1表达来评估罹患乳腺癌或卵巢癌的风险的方法。

著录项

公开/公告号US2013084564A1

专利类型
公开/公告日2013-04-04

原文格式PDF
申请/专利权人 SYLVIE MAZOYER;CHLOE TESSEREAU;MAURIZIO CEPPI;KEVIN CHEESEMAN;
展开▼

申请/专利号US201213486753
发明设计人 KEVIN CHEESEMAN;SYLVIE MAZOYER;MAURIZIO CEPPI;CHLOE TESSEREAU;
展开▼

申请日2012-06-01
分类号C12Q1/68;
国家 US
入库时间 2022-08-21 16:47:49

相似文献

专利
外文文献
中文文献

1. Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening:A cross-sectional population-based analysis [J] . Hongda Chen, Le Wang, Ming Lu, 中国癌症研究（英文版） . 2021,第004期

2. Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing [J] . Tessereau Chloe, Lesecque Yann, Monnet Nastasia, Nucleic Acids Research . 2014,第14期

3. Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing [J] . Tessereau Chloe, Lesecque Yann, Monnet Nastasia, Nucleic Acids Research . 2014,第14期

4. A comprehensive BRCA1/2 NGS pipeline for an immediate Copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosis [J] . Concolino Paola, Rizza Roberta, Mignone Flavio, Clinica chimica acta: International journal of clinical chemistry and applied molecular biology . 2018,第期

5. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and Fluorescence In Situ Hybridization in a Cohort of 220 Advanced Gastric Cancer Tissues [C] . Kyoung-Mee Kim, Soomin Ahn, Mineui Hong, International Molecular Medicine Tri-Conference. . 2016

6. Segregation analyses in Ashkenazi Jewish families: Evidence of an additional breast cancer susceptibility gene, and evaluation of cancer risks in BRCA1/2 mutation carriers. [D] . Kaufman, David J. 2002

7. Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing [O] . Chloé Tessereau, Yann Lesecque, Nastasia Monnet, 2014

8. Direct visualization of the highly polymorphic RNU2 locus in proximity to the BRCA1 gene. [O] . Chloé Tessereau, Monique Buisson, Nastasia Monnet, 2013

1. CNVs Associated with Susceptibility to Cancers: A Mini-Review [J] . Tomoko Furuya ,Yutaka Suehiro ,Yukihisa Namiki . 癌症治疗（英文） . 2015,第5期

2. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage Ⅳ colorectal cancer [J] . Jong Lyul Lee ,Seon Ae Roh ,Chan Wook Kim . 世界胃肠病学杂志：英文版 . 2019,第11期

3. Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool [J] . Hassan Tariq ,Muhammad Umar Kamal ,Harish Patel . 世界胃肠病学杂志：英文版 . 2018,第34期

4. Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers [J] . Robert L Metcalf ,Eamon Al-Hadithi ,Nicholas Hopley . 世界胃肠肿瘤学杂志：英文版（电子版） . 2017,第9期

5. 基于IB-LBM的尾流与壁面湍流之间的涡旋相互作用 [C] . LI Jiang-hua ,李姜华 ,LI Jia-hua . 第二十九届全国水动力学研讨会 . 2018

6. 基于iTRAQ技术对CNV的蛋白组学研究及TAB1对CNV的保护作用 [A] . 蒋少秋 . 2020